Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1070)	3/20/1998 1:01:00 PM
From: Walter Morton	Respond to of 2742

I am no stock value expert, but I have been told that a stocks price is based upon its expected earning in the coming years. If Cistron has cash worth $.58 per share and a stock price worth $.21, then the market does not believe Cistron knows what to do with that cash to generate increased earnings in the future. I would have thought that the increased investment in research and development would have calmed the market. Why doesn't the market have any confidence in Cistron's future?